
This phase zzso study assessed the maximum tolerated dose zzso safety, and zzso of zzso (a zzso zzso of zzso receptors 1, 2, and 3; zzso growth factor zzso and zzso administered once daily zzso or twice daily zzso in combination with zzso and zzso in patients with solid zzso 

Patients received weekly intravenous zzso zzso zzso and zzso zzso zzso zzso alone zzso zzso or in combination with zzso zzso zzso zzso 75 zzso zzso 125 zzso zzso or 100 zzso zzso zzso zzso or zzso zzso zzso zzso in combination with zzso zzso or 125 zzso zzso zzso 5 and zzso 

zzso patients were enrolled and received zzso zzso zzso zzso occurred in 11 patients in zzso 1 zzso zzso zzso 2 zzso zzso zzso 3 zzso zzso zzso and 6 zzso zzso zzso The zzso of zzso in combination with zzso and zzso was 100 zzso zzso zzso 125 zzso zzso was tolerable only in combination with zzso zzso Frequently occurring zzso adverse events included zzso zzso zzso zzso zzso zzso zzso zzso vomiting zzso zzso zzso and fatigue zzso zzso zzso which were mostly of worst grade zzso zzso The zzso of zzso was not markedly affected by zzso of zzso and zzso or zzso zzso zzso exposure, however, appeared lower after zzso with zzso and/or zzso Of 49 zzso patients, 1 had a confirmed partial response and 26 had stable zzso 

Treatment with zzso 100 zzso zzso plus zzso and zzso was zzso zzso 125 zzso zzso was tolerable only in combination with zzso zzso 

zzso zzso 

